Cost effectiveness of coronary prevention.
Szucs
T D
TD
März
W
W
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000191:economics*; D003327:Coronary Disease / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D017035:Pravastatin / Q000008:administration & dosage / Q000191:economics*; D011322:Primary Prevention / Q000191:economics*; D006113:United Kingdom
D000924:Anticholesteremic Agents; D017035:Pravastatin